Focal Interest
Focal Interest

Drug industry

  1. Industry payments were linked to more brand-name MS prescribing
    Pharmaceutical payments to clinicians correlated with reduced generic prescribing for MS medications, increasing costs for patients and the healthcare system overall.
  2. Equity concentration lowered firm value in China’s high-tech manufacturing
    Study examines how equity concentration affects firm value in China's high-tech manufacturing sector during 2019-2023, accounting for COVID-19 pandemic impacts using instrumental variable.
  3. Most favored nation drug pricing may lower industry research revenue
    Analysis of most favored nation drug pricing as policy mechanism to reduce international price disparities and effects on pharmaceutical research investment and innovation.
  4. Review compares academic and commercial liver-on-a-chip models
    Review of liver-on-a-chip models comparing academic and commercial platforms, examining designs, cellular compositions, and potential to reduce drug development costs and animal testing.